{"transactions":[{"id":671019,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":17916,"kind":"person","name":"DelAversano Robert J","position":1,"cik":"0001728262","reported_name":"DelAversano Robert J","relationship":{"officer":true,"officer_title":"Principal Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-01T20:05:15.000Z","date":"2026-08-28","kind":"grant","planned":false,"acquired":true,"shares":33660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest quarterly in substantially equal installments over a three-year period, subject to the Reporting Person's continuous service as of each vesting date, The first 1/12 tranche shall vest immediately upon the grant date with the remaining 11/12 vesting equally over the following 11 quarters starting on the three-month anniversary of the grant date."}],"balance_after":33660,"derivative":{"exercise_price":2.12,"expiration_date":"2036-08-27","underlying":"Common Stock","underlying_shares":33660},"source":{"system":"sec-edgar","filing":"0001140361-26-035316","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444192/000114036126035316/form4.xml","form_type":"4"}},{"id":1170963,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":17916,"kind":"person","name":"DelAversano Robert J","position":1,"cik":"0001728262","reported_name":"DelAversano Robert J","relationship":{"officer":true,"officer_title":"Principal Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-17T00:58:50.000Z","date":"2025-04-14","kind":"grant","planned":false,"acquired":true,"shares":20130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests quarterly in substantially equal installments over a 3-year period, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":20130,"derivative":{"exercise_price":2.08,"expiration_date":"2035-04-14","underlying":"Common Stock","underlying_shares":20130},"source":{"system":"sec-edgar","filing":"0001140361-25-014264","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444192/000114036125014264/form4.xml","form_type":"4"}},{"id":1523230,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":17916,"kind":"person","name":"DelAversano Robert J","position":1,"cik":"0001728262","reported_name":"DelAversano Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Financial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-05-08T23:18:46.000Z","date":"2024-05-06","kind":"grant","planned":false,"acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options granted on 05/06/2024 under the Acasti Pharma Stock Option Plan, which vest quarterly in equal installments over a 36-month period."}],"balance_after":4500,"derivative":{"exercise_price":2.96,"expiration_date":"2034-05-06","underlying":"Class A Common Shares","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0000950170-24-056082","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444192/000095017024056082/ownership.xml","form_type":"4"}},{"id":2024640,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":17916,"kind":"person","name":"DelAversano Robert J","position":1,"cik":"0001728262","reported_name":"DelAversano Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance"}}],"security":"Common Stock","published_at":"2023-02-09T20:11:50.000Z","date":"2023-02-09","kind":"sale","acquired":false,"shares":40,"price":1.37,"value":54.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the vesting of 49 RSUs on February 1, 2023, a total of 40 shares were sold in order to satisfy the reporting person's tax withholding obligations. The reporting person had no control with respect to such sale, which was conducted in accordance with the Issuer's corporate policies."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective as of 12:01 a.m. Eastern Time on November 9, 2022, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-22."}],"balance_after":1008,"source":{"system":"sec-edgar","filing":"0001493152-23-004168","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315223004168/ownership.xml","form_type":"4"}},{"id":2124346,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":17916,"kind":"person","name":"DelAversano Robert J","position":1,"cik":"0001728262","reported_name":"DelAversano Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance"}}],"security":"Common Stock","published_at":"2022-11-04T20:21:02.000Z","date":"2022-11-04","kind":"sale","acquired":false,"shares":283,"price":0.37,"value":104.71,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the vesting of 1,093 RSUs on November 1, 2022, a total of 283 shares were sold in order to satisfy the reporting person's tax withholding obligations. This sale occurred automatically, and the amount sold corresponded to the tax withholding amount. The reporting person had no control with respect to such sale, which was conducted in accordance with the Issuer's corporate policies."}],"balance_after":22975,"source":{"system":"sec-edgar","filing":"0001493152-22-030744","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315222030744/ownership.xml","form_type":"4"}},{"id":2193126,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":17916,"kind":"person","name":"DelAversano Robert J","position":1,"cik":"0001728262","reported_name":"DelAversano Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance"}}],"security":"Common Stock","published_at":"2022-08-05T20:00:20.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":284,"price":0.71,"value":201.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the vesting of 1,094 RSUs on August 1, 2022, a total of 284 shares were sold in order to satisfy the reporting person's tax withholding obligations. This sale occurred automatically, and the amount sold corresponded to the tax withholding amount. The reporting person had no control with respect to such sale, which was conducted in accordance with the Issuer's corporate policies."}],"balance_after":23258,"source":{"system":"sec-edgar","filing":"0001493152-22-021536","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315222021536/ownership.xml","form_type":"4"}},{"id":2279224,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":17916,"kind":"person","name":"DelAversano Robert J","position":1,"cik":"0001728262","reported_name":"DelAversano Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance"}}],"security":"Common Stock","published_at":"2022-05-06T12:35:41.000Z","date":"2022-05-06","kind":"sale","acquired":false,"shares":274,"price":0.83,"value":227.42,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the vesting of 1,094 RSUs on May 1, 2022, a total of 274 shares were sold on May 6, 2022, in order to satisfy the reporting person's tax withholding obligations. This sale occurred automatically, and the amount sold corresponded to the tax withholding amount. The reporting person had no control with respect to such sale, which was conducted in accordance with the Issuer's corporate policies."}],"balance_after":23542,"source":{"system":"sec-edgar","filing":"0001493152-22-012337","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315222012337/ownership.xml","form_type":"4"}},{"id":2401477,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":17916,"kind":"person","name":"DelAversano Robert J","position":1,"cik":"0001728262","reported_name":"DelAversano Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance"}}],"security":"Common Stock","published_at":"2022-02-11T20:00:38.000Z","date":"2022-02-09","kind":"sale","acquired":false,"shares":409,"price":0.88,"value":359.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 1,094 RSUs on February 1, 2022, a total of 409 shares were sold in order to satisfy the reporting person's tax withholding obligations. This sale occurred automatically, and the amount sold corresponded to the tax withholding amount. The reporting person had no control with respect to such sale, which was conducted in accordance with the Issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the vesting of 1,094 RSUs on February 1, 2022, a total of 409 shares were sold in order to satisfy the reporting person's tax withholding obligations. This sale occurred automatically, and the amount sold corresponded to the tax withholding amount. The reporting person had no control with respect to such sale, which was conducted in accordance with the Issuer's corporate policies."}],"balance_after":23816,"source":{"system":"sec-edgar","filing":"0001493152-22-004150","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315222004150/ownership.xml","form_type":"4"}},{"id":2526110,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":17916,"kind":"person","name":"DelAversano Robert J","position":1,"cik":"0001728262","reported_name":"DelAversano Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance"}}],"security":"Common Stock","published_at":"2021-11-03T20:00:10.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":343,"price":1.75,"value":600.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 1,093 RSUs on November 1, 2021, a total of 343 shares were sold in order to satisfy the reporting person's tax withholding obligations. This sale occurred automatically, and the amount sold corresponded to the tax withholding amount. The reporting person had no control with respect to such sale, which was conducted in accordance with the Issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the vesting of 1,093 RSUs on November 1, 2021, a total of 343 shares were sold in order to satisfy the reporting person's tax withholding obligations. This sale occurred automatically, and the amount sold corresponded to the tax withholding amount. The reporting person had no control with respect to such sale, which was conducted in accordance with the Issuer's corporate policies."}],"balance_after":24225,"source":{"system":"sec-edgar","filing":"0001493152-21-027164","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315221027164/ownership.xml","form_type":"4"}},{"id":2617513,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":17916,"kind":"person","name":"DelAversano Robert J","position":1,"cik":"0001728262","reported_name":"DelAversano Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance"}}],"security":"Common Stock","published_at":"2021-08-03T20:14:47.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":412,"price":2.18,"value":898.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 1,094 RSUs on August 1, 2021, a total of 412 shares were sold in order to satisfy the reporting person's tax withholding obligations. This sale occurred automatically, and the amount sold corresponded to the tax withholding amount. The reporting person had no control with respect to such sale, which was conducted in accordance with the Issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the vesting of 1,094 RSUs on August 1, 2021, a total of 412 shares were sold in order to satisfy the reporting person's tax withholding obligations. This sale occurred automatically, and the amount sold corresponded to the tax withholding amount. The reporting person had no control with respect to such sale, which was conducted in accordance with the Issuer's corporate policies."}],"balance_after":24568,"source":{"system":"sec-edgar","filing":"0001493152-21-018477","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315221018477/ownership.xml","form_type":"4"}},{"id":2651637,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":17916,"kind":"person","name":"DelAversano Robert J","position":1,"cik":"0001728262","reported_name":"DelAversano Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-29T19:43:42.000Z","date":"2021-06-28","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was 25% vested upon grant, and the remainder will vest in equal quarterly installments over the next two years."}],"balance_after":35000,"derivative":{"exercise_price":3.16,"exercise_date":"2021-06-28","expiration_date":"2031-06-28","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001493152-21-015622","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315221015622/ownership.xml","form_type":"4"}},{"id":2729941,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":17916,"kind":"person","name":"DelAversano Robert J","position":1,"cik":"0001728262","reported_name":"DelAversano Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance"}}],"security":"Common Stock","published_at":"2021-05-04T20:00:37.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":453,"price":4.86,"value":2201.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 1,094 RSUs on May 1, 2021, a total of 453 shares were sold in order to satisfy the reporting person's tax withholding obligations. This sale occurred automatically, and the amount sold corresponded to the tax withholding amount. The reporting person had no control with respect to such sale, which was conducted in accordance with the Issuer's corporate policies."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the vesting of 1,094 RSUs on May 1, 2021, a total of 453 shares were sold in order to satisfy the reporting person's tax withholding obligations. This sale occurred automatically, and the amount sold corresponded to the tax withholding amount. The reporting person had no control with respect to such sale, which was conducted in accordance with the Issuer's corporate policies."}],"balance_after":24980,"source":{"system":"sec-edgar","filing":"0001493152-21-010453","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315221010453/ownership.xml","form_type":"4"}},{"id":2881567,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":17916,"kind":"person","name":"DelAversano Robert J","position":1,"cik":"0001728262","reported_name":"DelAversano Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2021-02-03T21:42:04.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This is a long-term equity incentive award of restricted stock units which will vest quarterly over the next two years. The first vesting will occur on 5/1/2021, and the award will be fully vested on 2/1/2023, pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This is a long-term equity incentive award of restricted stock units which will vest quarterly over the next two years. The first vesting will occur on 5/1/2021, and the award will be fully vested on 2/1/2023, pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan."}],"balance_after":25433,"source":{"system":"sec-edgar","filing":"0001493152-21-002566","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315221002566/ownership.xml","form_type":"4"}},{"id":3046294,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":17916,"kind":"person","name":"DelAversano Robert J","position":1,"cik":"0001728262","reported_name":"DelAversano Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-26T20:00:10.000Z","date":"2020-08-24","kind":"grant","acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests quarterly over the next three years."}],"balance_after":27000,"derivative":{"exercise_price":3.82,"exercise_date":"2020-11-24","expiration_date":"2030-08-24","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001493152-20-016792","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315220016792/ownership.xml","form_type":"4"}},{"id":3123860,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":17916,"kind":"person","name":"DelAversano Robert J","position":1,"cik":"0001728262","reported_name":"DelAversano Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-03T21:16:22.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":54054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Issuer's Compensation Committee on April 14, 2020, subject to stockholder approval of an amendment to the Issuer's 2011 Incentive Plan to increase the number of authorized shares. The Issuer's stockholders approved the plan amendment on May 29, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was 25% vested on April 14, 2020, and the remainder vests quarterly over the next three years."}],"balance_after":54054,"derivative":{"exercise_price":1.56,"exercise_date":"2020-04-14","expiration_date":"2030-04-14","underlying":"Common Stock","underlying_shares":54054},"source":{"system":"sec-edgar","filing":"0001493152-20-010512","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315220010512/ownership.xml","form_type":"4"}},{"id":3123859,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":17916,"kind":"person","name":"DelAversano Robert J","position":1,"cik":"0001728262","reported_name":"DelAversano Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2020-06-03T21:16:22.000Z","date":"2020-05-29","kind":"tax_withholding","acquired":false,"shares":8679,"price":2.23,"value":19354.17,"ownership":{"direct":true},"balance_after":16683,"source":{"system":"sec-edgar","filing":"0001493152-20-010512","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315220010512/ownership.xml","form_type":"4"}},{"id":3123858,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":17916,"kind":"person","name":"DelAversano Robert J","position":1,"cik":"0001728262","reported_name":"DelAversano Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2020-06-03T21:16:22.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":25362,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25362,"source":{"system":"sec-edgar","filing":"0001493152-20-010512","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315220010512/ownership.xml","form_type":"4"}},{"id":3965122,"issuer":{"id":6127,"kind":"organization","name":"U.S. GOLD CORP."},"owners":[{"id":17916,"kind":"person","name":"DelAversano Robert J","position":1,"cik":"0001728262","reported_name":"DelAversano Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Option","published_at":"2018-04-12T20:05:25.000Z","date":"2018-04-10","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Option Award is compensation for the Reporting Person's service as Principal Financial and Accounting Officer of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an option award (the \"Option Award\") under the U.S. Gold Corp. Equity Incentive Plan, which Option Award shall vest in equal quarterly installments beginning on the 90 day anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":1.45,"expiration_date":"2023-04-10","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-18-005083","document":"form-4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/27093/000149315218005083/form-4.xml","form_type":"4"}}]}